UBS Group
NMTC icon

UBS Group’s NeuroOne Medical Technologies NMTC Stock Holding History

UBS Group’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84 Sell
18
-303
-94% -$1.46K ﹤0.01% 10141
2025
Q4 		$1.46K Buy
321
+27
+9% +$123 ﹤0.01% 9575
2025
Q3 		$1.57K Buy
294
+276
+1,533% +$1.35K ﹤0.01% 9316
2025
Q2 		$73 Hold
18
– – ﹤0.01% 10029
2025
Q1 		$92 Hold
18
– – ﹤0.01% 9956
2024
Q4 		$89 Hold
18
– – ﹤0.01% 9663
2024
Q3 		$107 Sell
18
-9,533
-100% -$47.7K ﹤0.01% 9153
2024
Q2 		$45.8K Buy
9,551
+9,533
+52,961% +$59.9K ﹤0.01% 6756
2024
Q1 		$130 Sell
18
-296
-94% -$2.24K ﹤0.01% 8797
2023
Q4 		$2.98K Buy
314
+296
+1,644% +$2.18K ﹤0.01% 8026
2023
Q3 		$96 Hold
18
– – ﹤0.01% 8898
2023
Q2 		$130 Hold
18
– – ﹤0.01% 8466
2023
Q1 		$174 Sell
18
-182
-91% -$1.69K ﹤0.01% 9158
2022
Q4 		$1.44K Buy
+200
New +$1.79K ﹤0.01% 9869
2022
Q3 		– Sell
-147
Closed -$1K – 10723
2022
Q2 		$1K Buy
+147
New +$818 ﹤0.01% 9918

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return